Quick Takeaways
- Inscobee Inc. filed SCHEDULE 13D/A for Apimeds Pharmaceuticals US, Inc. Common Stock (APUS).
- Disclosed ownership: 34%.
- Date of event: 20 Mar 2026.
Inscobee Inc. - 20 Mar 2026 SCHEDULE 13D/A Report for Apimeds Pharmaceuticals US, Inc. Common Stock (APUS)
- Filing Manager
- Inscobee Inc.
- Reporting Manager
- Apimeds Inc.
- Symbol
- APUS
- Shares outstanding
- 12,584,892 shares
- Disclosed Ownership
- 4,316,618 shares
- Ownership
- 34%
- Form type
- SCHEDULE 13D/A
- Filing time
- 20 Mar 2026, 18:21:23 UTC
- Date of event
- 20 Mar 2026
- Previous filing
- 26 Jan 2026
- Next filing
- 30 Mar 2026
- SEC
- View on sec.gov
Quoteable Key Fact
"Inscobee Inc. disclosed 34% ownership in Apimeds Pharmaceuticals US, Inc. Common Stock (APUS) on 20 Mar 2026."
What Changed
- Previous schedule filing date: 26 Jan 2026.
- Current filing was accepted on 20 Mar 2026, 18:21.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (2)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Inscobee Inc. | 17% | 2,099,747 | 2,099,747 | 0 | /s/ You In Soo | You In Soo, Chief Executive Officer | 0002057997 |
| Apimeds Inc. | 34% | 4,316,618 | 4,316,618 | 0 | /s/ You In Soo | You In Soo, Chief Executive Officer |